P. S. Randhawa has received the M.B.B.S. degree in medicine from the Delhi University, Delhi, India, in 1978, and the M.D. degree in pathology from the All India Institute of Medical Science, India, in 1983. He did a postdoctoral in medicine at the University of Miami in 1987. Randhawa completed his residency in pathology at the University of Pittsburgh from 1987 to 1991. He was an Assistant Professor of pathology at the University of Pittsburgh School of Medicine from 1991 to 1998, an Associate Professor of pathology at the University of Pittsburgh School of Medicine from 1999 to 2005, and a Professor of pathology at the University of Pittsburgh School of Medicine since 2005. Moreover, he received a fellowship from the National Center for Drug Discovery in Neurodegeneration, Harvard Medical School, in 2009; a mentorship from the College of American Pathologists Research, Scholars Grant, in 2009; and a fellowship of The American Society of Nephrology in 2004. In addition, Randhawa was honored the Mentorship Award at Thomas E Starzl Institute, and he was a Fellow of transplantation biology in 2007. His ongoing research projects include in vitro drug screening program at the NIH (Principal Investigator: Parmjeet Randhawa) which seeks to ascertain the anti-BKV activity of drugs referred to the NIAID by commercial and academic sponsors, immune response to polyomavirus infection at the NIH RO1 AI (role: principal investigator) which seeks to define the humoral and cell mediated immune response to BKV infection in healthy subjects and kidney transplant recipients, and polyomavirus infection after kidney transplantation at the NIH RO1 AI51227 (role: principal investigator) which seeks to study the molecular diversity of BK virus in clinical samples, characterize the role of smoldering BKV infections in the development of chronic allograft nephropathy, and utilize three-dimensional homology modeling and virtual screening approaches to anti-BKV drug discovery.
Biography Updated on 15 November 2011